Alpha-1 antitrypsin deficiency
Research activity includes Pi*ZZ alpha-1 antitrypsin deficiency, with attention to the clinical needs of adults affected by this inherited liver and lung disease. The funded studies reflect interest in disease-modifying approaches for a rare genetic disorder associated with protein misfolding and tissue injury.
- AATD
- Pi*ZZ genotype
- Inherited protein deficiency
- Hepatic and pulmonary disease
Clinical work in this area is centered on therapeutic development for a rare disease population with unmet need in both respiratory and hepatic care.
Overweight and obesity
The sponsor also supports research in adults living with overweight or obesity, focusing on a common metabolic condition linked to cardiometabolic risk and long-term weight management challenges.
- Obesity
- Weight management
- Metabolic health
- Adult population
This area of interest aligns with therapeutic development for chronic conditions where treatment options are closely tied to improving metabolic outcomes and body-weight regulation.
